| abstract |
The present disclosure provides a heterocyclic compound of formula (I), and also discloses a pharmaceutical composition comprising one of the heterocyclic compounds. Further disclosed are methods for using one of the heterocyclic compounds to drive hematopoietic stem cells and endothelial precursor cells into the peripheral circulation, and methods for treating tissue injury, cancer, inflammatory diseases, and autoimmune diseases. |